title: An unusual case of risperidone instability in a fatality presenting an analytical and interpretative challenge.
abstract: This paper describes the detection and characterization of unusual metabolite/breakdown products of the anti-psychotic drug risperidone in post-mortem blood and urine as part of a toxicological investigation into an unexpected death of a male suffering from paranoid schizophrenia prescribed risperidone and previously paroxetine. Compounds detected in the post-mortem blood and urine specimens were shown to be benzisoxazole ring scission products of risperidone and a hydroxy metabolite. These compounds are never routinely detected in blood and urine but can be present in mammalian faeces indicating that gut bacteria could be responsible for their formation. In this case, evidence for this process was demonstrated by the controlled in vitro stability study of risperidone spiked into the case blood and urine leading to the hypothesis that the post-mortem blood and urine samples analyzed could have contained bacteria with the ability to breakdown risperidone and its metabolite in this way. This finding is very unusual and has not been encountered before in any previous risperidone cases investigated by the authors, or widely reported in the post-mortem toxicological literature. However, a recently published paper has supported these findings in blood. As a result of this work, it was shown that the deceased had taken risperidone prior to death, even in the absence of any risperidone or its hydroxy metabolite(s) in the blood and urine. Given that risperidone has been reported to interact with paroxetine, the ingestion of risperidone could have been a factor that contributed to the death.
authors.affiliation: Forensics Ltd, Malvern Hills Science Park, Geraldine Road, Malvern, Worcestershire, WR14 3SZ, UK.
authors.forename: Kerry
authors.initials: K
authors.lastname: Taylor
authors.forename: Simon
authors.initials: S
authors.lastname: Elliott
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D014150:Antipsychotic Agents / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use* / Q000652:urine; D001344:Autopsy; D004355:Drug Stability; D006801:Humans; D008297:Male; D017374:Paroxetine / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D018967:Risperidone / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use* / Q000652:urine; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D017374:Paroxetine; D018967:Risperidone
keywords: benzisoxazole scission; paroxetine; risperidone